359 related articles for article (PubMed ID: 32807512)
41. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
[TBL] [Abstract][Full Text] [Related]
42. COVID-19: gastrointestinal and hepatobiliary manifestations.
Shih AR; Misdraji J
Hum Pathol; 2023 Feb; 132():39-55. PubMed ID: 35843340
[TBL] [Abstract][Full Text] [Related]
43. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis.
Mao R; Qiu Y; He JS; Tan JY; Li XH; Liang J; Shen J; Zhu LR; Chen Y; Iacucci M; Ng SC; Ghosh S; Chen MH
Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):667-678. PubMed ID: 32405603
[TBL] [Abstract][Full Text] [Related]
44. Factors Associated With Chronic De Novo Post-Coronavirus Disease Gastrointestinal Disorders in a Metropolitan US County.
Vélez C; Paz M; Silvernale C; Stratton LW; Kuo B; Staller K;
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):e1488-e1492. PubMed ID: 34687967
[TBL] [Abstract][Full Text] [Related]
45. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.
Najjar S; Najjar A; Chong DJ; Pramanik BK; Kirsch C; Kuzniecky RI; Pacia SV; Azhar S
J Neuroinflammation; 2020 Aug; 17(1):231. PubMed ID: 32758257
[TBL] [Abstract][Full Text] [Related]
46. Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19.
Zhang J; Garrett S; Sun J
Genes Dis; 2021 Jul; 8(4):385-400. PubMed ID: 33521210
[TBL] [Abstract][Full Text] [Related]
47. COVID-19 gastrointestinal manifestations: a systematic review.
Silva FAFD; Brito BB; Santos MLC; Marques HS; Silva Júnior RTD; Carvalho LS; Vieira ES; Oliveira MV; Melo FF
Rev Soc Bras Med Trop; 2020; 53():e20200714. PubMed ID: 33263693
[TBL] [Abstract][Full Text] [Related]
48. Gastrointestinal manifestations and possible mechanisms of COVID-19 in different periods.
Zhang MM; Chen LN; Qian JM
J Dig Dis; 2021 Dec; 22(12):683-694. PubMed ID: 34738727
[TBL] [Abstract][Full Text] [Related]
49. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
[TBL] [Abstract][Full Text] [Related]
50. Pathogenesis and Mechanisms of SARS-CoV-2 Infection in the Intestine, Liver, and Pancreas.
Khreefa Z; Barbier MT; Koksal AR; Love G; Del Valle L
Cells; 2023 Jan; 12(2):. PubMed ID: 36672197
[TBL] [Abstract][Full Text] [Related]
51. Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold'.
Stefano GB; Kream RM
Med Sci Monit; 2020 Nov; 26():e929789. PubMed ID: 33239605
[TBL] [Abstract][Full Text] [Related]
52. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
53. Novelty in the gut: a systematic review and meta-analysis of the gastrointestinal manifestations of COVID-19.
Suresh Kumar VC; Mukherjee S; Harne PS; Subedi A; Ganapathy MK; Patthipati VS; Sapkota B
BMJ Open Gastroenterol; 2020 May; 7(1):. PubMed ID: 32457035
[TBL] [Abstract][Full Text] [Related]
54. Clinical Characteristics of COVID-19 Patients with Gastrointestinal Symptoms.
Montazeri M; Maghbouli N; Jamali R; Sharifi A; Pazoki M; Salimzadeh A; Barzegari B; Rafiei N; Mansouri ES; Hadadi A
Arch Iran Med; 2021 Feb; 24(2):131-138. PubMed ID: 33636982
[TBL] [Abstract][Full Text] [Related]
55. Gastrointestinal and liver manifestations of COVID-19.
Cheong J; Bartell N; Peeraphatdit T; Mosli M; Al-Judaibi B
Saudi J Gastroenterol; 2020; 26(5):226-232. PubMed ID: 32367837
[TBL] [Abstract][Full Text] [Related]
56. Interaction between hepatitis B virus and SARS-CoV-2 infections.
Xiang TD; Zheng X
World J Gastroenterol; 2021 Mar; 27(9):782-793. PubMed ID: 33727770
[TBL] [Abstract][Full Text] [Related]
57. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study.
Lindan CE; Mankad K; Ram D; Kociolek LK; Silvera VM; Boddaert N; Stivaros SM; Palasis S;
Lancet Child Adolesc Health; 2021 Mar; 5(3):167-177. PubMed ID: 33338439
[TBL] [Abstract][Full Text] [Related]
58. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
59. Cardiac manifestations of COVID-19.
Bielecka-Dabrowa A; Cichocka-Radwan A; Lewek J; Pawliczak F; Maciejewski M; Banach M
Rev Cardiovasc Med; 2021 Jun; 22(2):365-371. PubMed ID: 34258904
[TBL] [Abstract][Full Text] [Related]
60. Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19.
De Toma I; Dierssen M
Sci Rep; 2021 Jan; 11(1):1930. PubMed ID: 33479353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
